Analysis of chromosomes 9 and 11 aneuploidy frequency in pleural effusion of patients with and without malignancy: Interphase FISH technique

Cancer Biology and Therapy

Volumn 4, Issue 2, 2005, Pages 248-251

  Cora, Tülin ^a   Acar, Hasan ^a   Ceran, Sami ^a   Bodur, Said ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Aneuploidy; Chromosome 9 and 11; Effusion; Interphase FISH

Indexed keywords

ADENOCARCINOMA; ANEUPLOIDY; ARTICLE; CENTROMERE; CHROMOSOME 11; CHROMOSOME 9; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MALIGNANT MESOTHELIOMA; PLEURA EFFUSION; SMALL CELL CARCINOMA;

ADENOCARCINOMA; ANEUPLOIDY; ASCITES; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; CENTROMERE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MESOTHELIOMA; NEOPLASMS; PLEURAL EFFUSION;

EID: 25144488116     PISSN: 15384047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
2. Weinberg R. Oncogenes, antioncogenes, and the the molecular basis of multistep carcinogenesis. Cancer Res 1989; 49:3713-21.
3. Chen Z, Wang DD, Peier A, Stone JF, Sandberg AA. FISH in the evaluation of pleural and acidic fluids. Cancer Genet Cytogenet 1995; 84:116-9.
4. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusion. Acta Cytol 1987; 1:85-97.
5. Cajulis RS, Yu GH, Gokaslan ST, Hidvegi DF. Modified interphase cytogenetics technique as an adjunct in the analysis of atypical cells in body fluids. Diagn Cytopathol 1997; 16:331-510.
6. Zojer N, Fiegl M, Angerler J, Mullauer L, Gsur A, Roka S, Pecherstorfer M, Huber H, Drach J. In terphase fluorescence in situ hybridization improves the detection of malignant cells in effusion from breast cancer patients. Br J Cancer 1997; 75:403-7.
7. Joseph MG, Banjeree D, Harris P, Gibson S, McFadden RG. Multiparameter flow cytometric DNA analysis of effusion: A prospective study of 36 cases compared with routine cytology and immunohistochemistry. Mod Pathol 1995; 8:686-93.
8. Heller T, Trautmann B, Zöller-Utz I, Konig HJ, Liebe S, Ell C, Lohr M. Demonstration by restriction enzyme mismatch polymerase chain reaction of point mutations of the Ki-ras oncogene in carcinoma of the pancreas. Dtsch Med Wochenschr 1995; 120:826-30.
9. Bousfield LR, Greenberg ML, Pacey F. Cytogenetic diagnosis of cancer from body fluids. Acta Cytol 1985; 29:768-74.
10. Dewald GW, Dines DA, Weiland LH. Usefulness of chromosome examination in the diagnosis of malignant pleural effusion. N Engl J Med 1976; 295:1494-500.
11. Schenk T, Ackermann J, Brunner C, Schenk P, Zojer N, Roka S, et al. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest 1997; 111:1691-6.
12. Shin HJC, Shin DM, Tarco E, Sneige N. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma. Cancer (Cancer Cytopathol) 2003; 20:233-9.
13. Zojer N, Fiegl M, Mullauer L, Chott A, Roka S, Ackermann J, Raderer M, Kaufmann H, Reiner A, Huber H, Drach J. Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: Basic findings and clinical aspects. Br J Cancer 1998; 77:1337-42.
14. Tsukamoto M, Matsuyama H, Oba K, Yoshihiro S, Takahashi M, Naito K. Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence. Cance r Genet Cytogenet 2002; 134:41-5.
15. Eleuteri P, Grollino MG, Pomponi RdV. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. Europ J Cancer 2001; 37:1496-503.
16. Fiegl M, Tueni C, Schenk T, Jakesz R, Gnant M, Reiner A, Rudas M, Pirc-Danoewinata H, Marosi C, Huber H, et al. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer 1995; 72:51-5.
17. Acar H, Kilinç M, Yildirim MS, Kaynak M, Cenker A. Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Cance Genet Cytogenet 2003; 142:25-9.
18. Johnson TM, Kuffel DG, Deward GW. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization. Mayo Clin Proc 1996; 1:643-8.
19. Florentina BD, Sanchez B, Raza A, Frankel K, Martin SE, Kovacs B, Felix JC. Detection of hyperdiploid malignant cells in body cavity effusions by fluorescence in situ hybridization on ThinPrep slides. Cancer (Cancer Cytopathol) 1997; 81:299-38.
20. Tiainen M, Tammilehto L, Mattson K, Knuutila S. Non-random chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet 1998; 33:251-74.
21. Fiegl M, Zojer N, Kaufmann H, Müllauer L, Schuster R, Huber H, Drach J. Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH). Cytometry (Comm Clin Cytometry) 1999; 38:15-23.
22. Jia D, Zhang Z, Liu S, Cheng S. Study on interphase cytogenetic abnormalities in malignant cells in pleural fluids from lung cancer cases. Zhonghuo Yi Xue Ke Xue Yuan Xue Bao 2000; 17:244-7
23. Ioakim-Liossi A, Gagos S, Athanassiades P, Athanassiades P, Gogas J, Dvaris P, Markopoulos C. Changes of chromosomes 1, 3, 6, and 11 in metastatic effusions arising from breast and ovarian cancer. Cancer Genet Cytogenet 1999; 110:34-40.
24. Roka S, Fiegl M, Zojer N, Filipits M, Schuster R, Steiner B, Jakesz R, Huber H, Drach J. Aneuploidy of chromosome 8 as detected by interp hase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat 1998; 48:125-33.
25. Fiegl M, Kaufmann H, Zojer N, Schuster R, Wiener H, Müllauer L, Roka S, Huber H, Drach J. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol 2000; 31:448-55.